Breaking News
Can MMR Vaccines Defend Against SARS-CoV-2 Infection?
September 20, 2020 • 11:35 am CDT
The Washington University School of Medicine announced on September 3, 2020, it is the clinical coordinating center for an ambitious, international clinical trial, which is the first to evaluate on a large scale whether the common MMR vaccine can protect against COVID-19.
Data from the trial sites will be compiled at University College London. Laurence Lovat, M.D., Ph.D., a professor of gastroenterology and biophotonics, is the study leader in the United Kingdom. “If we discover that the MMR vaccine can help train the body’s immune response to SARS-CoV-2 infection, then we will have something to administer very quickly while waiting for more specific vaccines and preventive therapies to be developed,”
Medical Review by